Clinical Trial Update: Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating capecitabine, paclitaxel, and trastuzumab in metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Taxol (paclitaxel)
• Xeloda (capecitabine)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED